期刊文献+

T1 mapping技术用于评估心尖肥厚型心肌病患者心肌钆沉积

T1 mapping technique for evaluating myocardial gadolinium deposition in patients with apical hypertrophic cardiomyopathy
下载PDF
导出
摘要 目的观察T1 mapping技术用于评估心尖肥厚型心肌病(AHCM)患者心肌钆沉积的可行性。方法回顾性分析60例AHCM患者资料,根据是否接受含钆对比剂(GBCA)注射分为增强组和对照组各30例;基于2组心脏T1 mapping测量左心室基底部、中间部、心尖部心肌T1值及相应层面脾脏T1值,计算T1相对值(T1R),比较组间及增强组内左心室不同部位心肌T1R,并对增强组T1R基于性别、年龄、体质量指数、心功能、高血压、高血脂、糖尿病、心尖厚度、射血分数、延迟强化、首次增强检查至末次复查间隔时间及GBCA总量进行进一步分析。结果组间T1R_(基底部)、T1R_(中间部)、T1R_(心尖部)差异均无统计学意义(t=0.329、1.484、0.720,P均>0.05)。增强组内,左心室不同部位心肌T1R差异无统计学意义(F=0.765,P>0.05),不同性别及有无高血压患者间心肌T1R差异均有统计学意义(P均<0.05)。结论T1 mapping技术可用于评估AHCM患者心肌钆沉积。 Objective To observe the feasibility of T1 mapping technique for evaluating myocardial gadolinium deposition in patients with apical hypertrophic cardiomyopathy(AHCM).Methods Data of 60 AHCM patients were retrospectively analyzed.The patients were divided into enhanced group and control group according to underwent gadolinium-based contrast agent(GBCA)enhanced examination or not(each n=30).Myocardial T1 value at the basal,middle and apical myocardium of the left ventricle as well as spleen T1 at the same layers were measured.T1 relative-value(T1R)was calculated and then compared between groups and among different parts of left ventricle in enhanced group.T1R in enhanced group were further analyzed based on gender,age,body mass index,cardiac function,hypertension,hyperlipidemia,diabetes,apical thickness,ejection fraction,delayed enhancement and interval time from the first enhanced examination to the last review and total dose of GBCA.Results No significant difference of T1R_(basal),T1R_(middle) nor T1R _(apical) was found between groups(t=0.329,1.484,0.720,all P>0.05),nor of T1R in different parts of left ventricle within enhanced group(F=0.765,P>0.05).In enhanced group,significant differences of myocardial T1R was found between different genders as well as patients with or without hypertension(both P<0.05).Conclusion T1 mapping technology could be used for evaluating myocardial gadolinium deposition in patients with AHCM.
作者 杨宏志 兰天 杨如武 YANG Hongzhi;LAN Tian;YANG Ruwu(Department of Medical Imaging,Xidian Group Hospital,Xi'an 710077,China;Department of Magnetic Resonance Imaging,Peking Union Medical College&Chinese Academy of Medical Sciences,Fuwai Hospital,National Center for Cardiovascular Diseases,Beijing 100037,China)
出处 《中国医学影像技术》 CSCD 北大核心 2024年第2期226-230,共5页 Chinese Journal of Medical Imaging Technology
关键词 心肌病 肥厚型 T1 mapping 心肌钆沉积 cardiomyopathy,hypertrophic T1 mapping myocardial gadolinium deposition
  • 相关文献

参考文献8

二级参考文献43

  • 1Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopa- thies. N Engl J Med, 2011,364(17) : 1643-1656.
  • 2Mewton N, Liu CY, Croisille P, et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coil Cardi- ol, 2011,57(8) :891-903.
  • 3Kim RJ, Judd RM. Gadolinium-enhanced magnetic resonance im- aging in hypertrophic cardiomyopathy: In vivo imaging of the pathologic substrate for premature cardiac death.9 J Am Coil Car- diol, 2003,41(9) : 1568-1572.
  • 4Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am CollCardiol, 2006,48(10) : 1977-1985.
  • 5Kellman P, Hansen MS. Tl-mapping in the heart: Accuracy and precision. JCMR, 2014,16 : 2.
  • 6Liu CY, Liu YC, Wu C, et al. Evaluation of age-related intersti- tial myocardial fibrosis with cardiac magnetic resonance contrast- enhanced T1 mapping: MESA (Multi-Ethnic Study of Athero- sclerosis). J Am Coil Cardiol, 2013,62(14) : 1280-1287.
  • 7Sibley CT, Noureldin RA, Gai N, et al. T1 Mapping in cardio- myopathy at cardiac MR: Comparison with endomyocardial biop- sy. Radiology, 2012,265 (3) : 724-732.
  • 8Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myoeardium from diffuse disease in hy- pertrophic and dilated cardiomyopathy. J Am Coil Cardiol Ima-ging, 2013,6(4):475-484.
  • 9Masci PG, Dou|aptsis C, Bertella E, et al. Incremental prognos- tic value of myocardial fibrosis in patients with non-ischemic car diomyopathy without congestive heart failure, Cire Heart Fail, 2014,7(3) :448-456.
  • 10Su MY, [.in LY, Tseng YH, et al. CMR verified diffuse myo cardial fibrosis is associated with diastolic dysfunction in HF- pEF. jAC(7 Cardiovasc Imaging, 2014,7(10):991 997.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部